Mechanism of Antibacterial Activity of Bacillus amyloliquefaciens C-1 Lipopeptide toward Anaerobic Clostridium difficile

Probiotics may offer an attractive alternative for standard antibiotic therapy to treat Clostridium difficile infections (CDI). In this study, the antibacterial mechanism in vitro of newly isolated B. amyloliquefaciens C-1 against C. difficile was investigated. The lipopeptides surfactin, iturin, an...

Descripción completa

Detalles Bibliográficos
Autores principales: Lv, Jia, Da, Rong, Cheng, Yue, Tuo, Xiaohong, Wei, Jie, Jiang, Kaichong, Monisayo, Adediji Omolade, Han, Bei
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi 2020
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7073505/
https://www.ncbi.nlm.nih.gov/pubmed/32190658
http://dx.doi.org/10.1155/2020/3104613

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7073505/
https://www.ncbi.nlm.nih.gov/pubmed/32190658
http://dx.doi.org/10.1155/2020/3104613

Ejemplares similares